TABLE 2.
All patients (n = 123) | Polyp patients (n = 82) | Nonpolypoid patients (n = 41) | |||||||
---|---|---|---|---|---|---|---|---|---|
n | Mean ± SD change | p | n | Mean ± SD change | p | n | Mean ± SD change | p | |
All patients | 123 | 25 ± 23 | 82 | 30 ± 21 | 0.002 | 41 | 16 ± 24 | 0.002 | |
Genotype | |||||||||
Non-PAV | 96 | 24 ± 22 | 0.13 | 62 | 30 ± 20 | 0.85 | 34 | 12 ± 22 | 0.006 |
PAV/PAV | 27 | 31 ± 25 | 20 | 29 ± 26 | 7 | 38 ± 21 | |||
Taste sensitivitya | |||||||||
PTC <5.5 | 41 | 25 ± 24 | 0.53 | 29 | 33 ± 19 | 0.80 | 12 | 4 ± 21 | 0.03 |
PTC ≥5.5 | 54 | 28 ± 23 | 34 | 31 ± 24 | 20 | 21 ± 20 | |||
Denatonium <4 | 34 | 27 ± 25 | 0.97 | 28 | 31 ± 23 | 0.76 | 6 | 5 ± 22 | 0.20 |
Denatonium ≥4 | 62 | 26 ± 22 | 36 | 33 ± 21 | 26 | 17 ± 21 | |||
Quinine <3 | 42 | 28 ± 25 | 0.45 | 29 | 34 ± 24 | 0.68 | 13 | 16 ± 23 | 0.89 |
Quinine ≥3 | 54 | 25 ± 22 | 35 | 31 ± 20 | 19 | 14 ± 21 | |||
Sucrose <6 | 43 | 25 ± 24 | 0.46 | 30 | 29 ± 23 | 0.27 | 13 | 14 ± 25 | 0.86 |
Sucrose ≥6 | 53 | 28 ± 22 | 34 | 35 ± 20 | 19 | 16 ± 20 | |||
Other variables | |||||||||
Female gender | 50 | 24 ± 24 | 0.6 | 26 | 34 ± 23 | 0.20 | 12.9 | 19.9 ± 13 | 0.272 |
Male gender | 73 | 26 ± 22 | 56 | 28 ± 20 | 21.2 | 28 ± 21 | |||
White | 111 | 24 ± 23 | 0.09 | 71 | 29 ± 22 | 0.25 | 16.0 | 24 ± 16 | |
Non-white | 12 | 36 ± 20 | 11 | 37 ± 21 | |||||
Age less than 50 years | 45 | 30 ± 21 | 0.07 | 35 | 33 ± 21 | 0.22 | 20.1 | 20 ± 20 | 0.566 |
Age 50 years or greater | 78 | 22 ± 24 | 47 | 27 ± 22 | 15.1 | 25 ± 15 | |||
Never smoked | 76 | 24 ± 20 | 0.35 | 54 | 28 ± 18 | 0.33 | 13.5 | 22.0 ± 14 | 0.368 |
Current or former smoker | 43 | 28 ± 26 | 26 | 34 ± 27 | 20.2 | 24 ± 20 | |||
Asthma | 72 | 27 ± 20 | 0.39 | 58 | 29 ± 19 | 0.60 | 17.9 | 21 ± 18 | 0.757 |
No asthma | 51 | 23 ± 27 | 24 | 32 ± 27 | 15.5 | 25 ± 16 | |||
ASA | 18 | 35 ± 20 | 0.06 | 18 | 35 ± 20 | 0.28 | 16.3 | ||
No ASA | 105 | 23.6 ± 23 | 64 | 28 ± 22 | |||||
Diabetes | 15 | 26 ± 18 | 0.79 | 10 | 31 ± 18 | 0.89 | 19.0 | 17 ± 19 | 0.790 |
No diabetes | 108 | 25 ± 24 | 72 | 30 ± 22 | 15.9 | 25 ± 16 | |||
No AFS | 98 | 25 ± 23 | 0.91 | 58 | 31 ± 22 | 0.60 | |||
AFS | 25 | 26 ± 23 | 24 | 28 ± 21 | |||||
Primary surgery | 32 | 22 ± 25 | 0.42 | 17 | 24 ± 25 | 0.18 | 21.3 | 26 ± 21 | 0.314 |
Revision surgery | 91 | 26 ± 22 | 65 | 31 ± 20 | 13.5 | 22 ± 14 | </TB> |
Values of p show whether each variable affects the difference between the preoperative and postoperative 6-month SNOT-22 scores.
For each taste sensitivity test, patients were categorized as having a taste intensity above or below the median score for the overall population (5.5, 4, 3, and 6, respectively, for PTC, denatonium, quinine, and sucrose).
AFS = allergic fungal sinusitis; ASA = acetylsalicylic acid; PAV = functional receptor haplotype containing proline, alanine, and valine; PTC = phenylthiocarbamide; SD = standard deviation; SNOT = Sino-Nasal Outcome Test.